ID   S29A4_HUMAN             Reviewed;         530 AA.
AC   Q7RTT9; Q6PJ08; Q86WY8; Q8NAR3; Q8NBM2;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 1.
DT   10-MAY-2017, entry version 114.
DE   RecName: Full=Equilibrative nucleoside transporter 4;
DE            Short=hENT4;
DE   AltName: Full=Plasma membrane monoamine transporter;
DE   AltName: Full=Solute carrier family 29 member 4;
GN   Name=SLC29A4; Synonyms=ENT4, PMAT; ORFNames=PSEC0113;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TOPOLOGY, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=15448143; DOI=10.1074/jbc.M407913200;
RA   Engel K., Zhou M., Wang J.;
RT   "Identification and characterization of a novel monoamine transporter
RT   in the human brain.";
RL   J. Biol. Chem. 279:50042-50049(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS GLU-79; LYS-124 AND THR-429.
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION.
RX   PubMed=12446811; DOI=10.1093/oxfordjournals.molbev.a004044;
RA   Acimovic Y., Coe I.R.;
RT   "Molecular evolution of the equilibrative nucleoside transporter
RT   family: identification of novel family members in prokaryotes and
RT   eukaryotes.";
RL   Mol. Biol. Evol. 19:2199-2210(2002).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, GLYCOSYLATION AT
RP   ASN-523, AND MUTAGENESIS OF GLU-206 AND GLU-375.
RX   PubMed=16873718; DOI=10.1161/01.RES.0000238359.18495.42;
RA   Barnes K., Dobrzynski H., Foppolo S., Beal P.R., Ismat F.,
RA   Scullion E.R., Sun L., Tellez J., Ritzel M.W., Claycomb W.C.,
RA   Cass C.E., Young J.D., Billeter-Clark R., Boyett M.R., Baldwin S.A.;
RT   "Distribution and functional characterization of equilibrative
RT   nucleoside transporter-4, a novel cardiac adenosine transporter
RT   activated at acidic pH.";
RL   Circ. Res. 99:510-519(2006).
RN   [7]
RP   FUNCTION, TOPOLOGY, AND TISSUE SPECIFICITY.
RX   PubMed=17018840; DOI=10.1152/ajprenal.00302.2006;
RA   Xia L., Engel K., Zhou M., Wang J.;
RT   "Membrane localization and pH-dependent transport of a newly cloned
RT   organic cation transporter (PMAT) in kidney cells.";
RL   Am. J. Physiol. 292:F682-F690(2007).
RN   [8]
RP   FUNCTION, AND MUTAGENESIS OF ASP-91; ASP-107; GLU-128; ASP-154;
RP   ASP-163; GLU-206; THR-220; GLU-227; GLU-242; TRP-336 AND GLU-375.
RX   PubMed=17121826; DOI=10.1074/jbc.M609421200;
RA   Zhou M., Xia L., Engel K., Wang J.;
RT   "Molecular determinants of substrate selectivity of a novel organic
RT   cation transporter (PMAT) in the SLC29 family.";
RL   J. Biol. Chem. 282:3188-3195(2007).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=17393420; DOI=10.1002/mrd.20697;
RA   Bottalico B., Noskova V., Pilka R., Larsson I., Domanski H.,
RA   Casslen B., Hansson S.R.;
RT   "The organic cation transporters (OCT1, OCT2, EMT) and the plasma
RT   membrane monoamine transporter (PMAT) show differential distribution
RT   and cyclic expression pattern in human endometrium and early pregnancy
RT   decidua.";
RL   Mol. Reprod. Dev. 74:1303-1311(2007).
CC   -!- FUNCTION: Functions as a polyspecific organic cation transporter,
CC       efficiently transporting many organic cations such as monoamine
CC       neurotransmitters 1-methyl-4-phenylpyridinium and biogenic amines
CC       including serotonin, dopamine, norepinephrine and epinephrine. May
CC       play a role in regulating central nervous system homeostasis of
CC       monoamine neurotransmitters. May be involved in luminal transport
CC       of organic cations in the kidney and seems to use luminal proton
CC       gradient to drive organic cation reabsorption. Does not seem to
CC       transport nucleoside and nucleoside analogs such as uridine,
CC       cytidine, thymidine, adenosine, inosine, guanosine, and
CC       azidothymidine. In (PubMed:16873718) adenosine is efficiently
CC       transported but in a fashion highly sensitive to extracellular pH,
CC       with maximal activity in the pH range 5.5 to 6.5. Glu-206 is
CC       essential for the cation selectivity and may function as the
CC       charge sensor for cationic substrates. Transport is chloride and
CC       sodium-independent but appears to be sensitive to changes in
CC       membrane potential. Weakly inhibited by the classical inhibitors
CC       of equilibrative nucleoside transport, dipyridamole, dilazep, and
CC       nitrobenzylthioinosine. May play a role in the regulation of
CC       extracellular adenosine concentrations in cardiac tissues, in
CC       particular during ischemia. {ECO:0000269|PubMed:15448143,
CC       ECO:0000269|PubMed:16873718, ECO:0000269|PubMed:17018840,
CC       ECO:0000269|PubMed:17121826}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000305}. Apical cell membrane
CC       {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
CC       Note=Located to the plasma membranes of ventricular myocytes and
CC       vascular endothelial cells. Targeted to the apical membranes of
CC       differentiated kidney epithelial cells.
CC       {ECO:0000269|PubMed:15448143, ECO:0000269|PubMed:16873718}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7RTT9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7RTT9-2; Sequence=VSP_032647;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in the heart, in both
CC       cardiomyocytes and vascular endothelial cells (at protein level).
CC       Highly expressed in brain, kidney and skeletal muscle. In the
CC       brain expressed in cerebellum, cerebral cortex, medulla, occipital
CC       pole, frontal and temporal lobes putamen and in the spinal cord.
CC       Lower expression in liver, pancreas, and liver. Expressed in
CC       endometrial tissue, exclusively in the stroma. Expression is high
CC       in the proliferative phase, decreases during the secretory phase,
CC       and is no longer detectable in the menstrual phase.
CC       {ECO:0000269|PubMed:15448143, ECO:0000269|PubMed:16873718,
CC       ECO:0000269|PubMed:17018840, ECO:0000269|PubMed:17393420}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:16873718}.
CC   -!- SIMILARITY: Belongs to the SLC29A/ENT transporter (TC 2.A.57)
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11612.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY485959; AAS65965.1; -; mRNA.
DR   EMBL; AK075422; BAC11612.1; ALT_INIT; mRNA.
DR   EMBL; AK092242; BAC03836.1; -; mRNA.
DR   EMBL; CH471144; EAW87329.1; -; Genomic_DNA.
DR   EMBL; CH471144; EAW87330.1; -; Genomic_DNA.
DR   EMBL; BC025325; AAH25325.1; -; mRNA.
DR   EMBL; BC047592; AAH47592.1; -; mRNA.
DR   EMBL; BK000627; DAA00308.1; -; Genomic_DNA.
DR   CCDS; CCDS5340.1; -. [Q7RTT9-1]
DR   CCDS; CCDS75561.1; -. [Q7RTT9-2]
DR   RefSeq; NP_001035751.1; NM_001040661.1. [Q7RTT9-1]
DR   RefSeq; NP_001287776.1; NM_001300847.1. [Q7RTT9-2]
DR   RefSeq; NP_694979.2; NM_153247.2. [Q7RTT9-1]
DR   RefSeq; XP_005249715.1; XM_005249658.4. [Q7RTT9-2]
DR   RefSeq; XP_006715730.1; XM_006715667.3. [Q7RTT9-1]
DR   RefSeq; XP_011513502.1; XM_011515200.2. [Q7RTT9-1]
DR   RefSeq; XP_011513503.1; XM_011515201.2. [Q7RTT9-1]
DR   UniGene; Hs.4302; -.
DR   ProteinModelPortal; Q7RTT9; -.
DR   STRING; 9606.ENSP00000297195; -.
DR   ChEMBL; CHEMBL3509593; -.
DR   DrugBank; DB00331; Metformin.
DR   GuidetoPHARMACOLOGY; 1120; -.
DR   TCDB; 2.A.57.1.5; the equilibrative nucleoside transporter (ent) family.
DR   iPTMnet; Q7RTT9; -.
DR   PhosphoSitePlus; Q7RTT9; -.
DR   BioMuta; SLC29A4; -.
DR   DMDM; 74713147; -.
DR   PaxDb; Q7RTT9; -.
DR   PeptideAtlas; Q7RTT9; -.
DR   PRIDE; Q7RTT9; -.
DR   Ensembl; ENST00000297195; ENSP00000297195; ENSG00000164638. [Q7RTT9-1]
DR   Ensembl; ENST00000396872; ENSP00000380081; ENSG00000164638. [Q7RTT9-1]
DR   Ensembl; ENST00000406453; ENSP00000385845; ENSG00000164638. [Q7RTT9-2]
DR   GeneID; 222962; -.
DR   KEGG; hsa:222962; -.
DR   UCSC; uc003soc.4; human. [Q7RTT9-1]
DR   CTD; 222962; -.
DR   DisGeNET; 222962; -.
DR   GeneCards; SLC29A4; -.
DR   HGNC; HGNC:23097; SLC29A4.
DR   HPA; HPA052829; -.
DR   MIM; 609149; gene.
DR   neXtProt; NX_Q7RTT9; -.
DR   OpenTargets; ENSG00000164638; -.
DR   PharmGKB; PA134976472; -.
DR   eggNOG; KOG1479; Eukaryota.
DR   eggNOG; ENOG410Y3MT; LUCA.
DR   GeneTree; ENSGT00390000002232; -.
DR   HOGENOM; HOG000048076; -.
DR   HOVERGEN; HBG095787; -.
DR   InParanoid; Q7RTT9; -.
DR   KO; K03323; -.
DR   OMA; FYTTRPR; -.
DR   OrthoDB; EOG091G0840; -.
DR   PhylomeDB; Q7RTT9; -.
DR   TreeFam; TF313950; -.
DR   Reactome; R-HSA-83936; Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane.
DR   ChiTaRS; SLC29A4; human.
DR   GeneWiki; SLC29A4; -.
DR   GenomeRNAi; 222962; -.
DR   PRO; PR:Q7RTT9; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164638; -.
DR   CleanEx; HS_SLC29A4; -.
DR   ExpressionAtlas; Q7RTT9; baseline and differential.
DR   Genevisible; Q7RTT9; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0008504; F:monoamine transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0005337; F:nucleoside transmembrane transporter activity; TAS:Reactome.
DR   InterPro; IPR030198; ENT4.
DR   InterPro; IPR002259; Eqnu_transpt.
DR   InterPro; IPR020846; MFS_dom.
DR   PANTHER; PTHR10332; PTHR10332; 1.
DR   PANTHER; PTHR10332:SF42; PTHR10332:SF42; 1.
DR   Pfam; PF01733; Nucleoside_tran; 1.
DR   PRINTS; PR01130; DERENTRNSPRT.
DR   SUPFAM; SSF103473; SSF103473; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Membrane; Polymorphism; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    530       Equilibrative nucleoside transporter 4.
FT                                /FTId=PRO_0000326251.
FT   TOPO_DOM      1     68       Extracellular. {ECO:0000255}.
FT   TRANSMEM     69     89       Helical. {ECO:0000255}.
FT   TOPO_DOM     90    101       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    102    122       Helical. {ECO:0000255}.
FT   TOPO_DOM    123    139       Extracellular. {ECO:0000255}.
FT   TRANSMEM    140    160       Helical. {ECO:0000255}.
FT   TOPO_DOM    161    166       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    167    187       Helical. {ECO:0000255}.
FT   TOPO_DOM    188    231       Extracellular. {ECO:0000255}.
FT   TRANSMEM    232    252       Helical. {ECO:0000255}.
FT   TOPO_DOM    253    351       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    352    372       Helical. {ECO:0000255}.
FT   TOPO_DOM    373    381       Extracellular. {ECO:0000255}.
FT   TRANSMEM    382    402       Helical. {ECO:0000255}.
FT   TOPO_DOM    403    416       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    417    437       Helical. {ECO:0000255}.
FT   TOPO_DOM    438    450       Extracellular. {ECO:0000255}.
FT   TRANSMEM    451    471       Helical. {ECO:0000255}.
FT   TOPO_DOM    472    486       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    487    509       Helical. {ECO:0000255}.
FT   TOPO_DOM    510    530       Extracellular. {ECO:0000255}.
FT   CARBOHYD    523    523       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     139    182       GYLLALGPLLFISICDVWLQLFSRDQAYAINLAAVGTVAFG
FT                                CTV -> ASATCGCSSSLGTRPTPSTWPLWAPWPSAA (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_032647.
FT   VARIANT      79     79       V -> E (in dbSNP:rs17854505).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_040044.
FT   VARIANT     124    124       N -> K (in dbSNP:rs17855675).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_040045.
FT   VARIANT     429    429       P -> T (in dbSNP:rs17857336).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_040046.
FT   MUTAGEN      91     91       D->A: No significant change in cationic
FT                                transport activity.
FT                                {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     107    107       D->A: Loss of cationic transport
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     128    128       E->A: No significant change in cationic
FT                                transport activity.
FT                                {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     154    154       D->A: Loss of cationic transport
FT                                activity; increase in uridine uptake.
FT                                {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     163    163       D->A: Loss of cationic transport
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     206    206       E->A: Loss of cationic transport
FT                                activity. {ECO:0000269|PubMed:16873718,
FT                                ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     206    206       E->D: No loss of cationic transporter
FT                                activity; no activity towards uridine.
FT                                {ECO:0000269|PubMed:16873718,
FT                                ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     206    206       E->Q: Loss of cationic transporter
FT                                activity; increase in uridine uptake.
FT                                {ECO:0000269|PubMed:16873718,
FT                                ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     206    206       E->R: Loss of cationic transporter
FT                                activity. {ECO:0000269|PubMed:16873718,
FT                                ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     220    220       T->A: Reduced cationic transport
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     220    220       T->I: Loss of cationic transporter
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     220    220       T->S: Reduced cationic transport
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     227    227       E->A: Functional with slight increased
FT                                cationic transport activity.
FT                                {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     242    242       E->A: Reduced cationic transport
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     336    336       W->A: Loss of cationic transport
FT                                activity. {ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     375    375       E->A: Functional with slight increased
FT                                cationic transport activity.
FT                                {ECO:0000269|PubMed:16873718,
FT                                ECO:0000269|PubMed:17121826}.
FT   MUTAGEN     375    375       E->Q: No change in cationic activity and
FT                                pH sensitivity.
FT                                {ECO:0000269|PubMed:16873718,
FT                                ECO:0000269|PubMed:17121826}.
FT   CONFLICT     25     25       S -> C (in Ref. 2; BAC03836).
FT                                {ECO:0000305}.
FT   CONFLICT     41     41       Q -> R (in Ref. 2; BAC03836).
FT                                {ECO:0000305}.
FT   CONFLICT    196    196       K -> R (in Ref. 2; BAC03836).
FT                                {ECO:0000305}.
FT   CONFLICT    261    261       Y -> H (in Ref. 2; BAC11612).
FT                                {ECO:0000305}.
FT   CONFLICT    301    301       L -> P (in Ref. 2; BAC03836).
FT                                {ECO:0000305}.
SQ   SEQUENCE   530 AA;  58059 MW;  3FE5D5ED1D248A13 CRC64;
     MGSVGSQRLE EPSVAGTPDP GVVMSFTFDS HQLEEAAEAA QGQGLRARGV PAFTDTTLDE
     PVPDDRYHAI YFAMLLAGVG FLLPYNSFIT DVDYLHHKYP GTSIVFDMSL TYILVALAAV
     LLNNVLVERL TLHTRITAGY LLALGPLLFI SICDVWLQLF SRDQAYAINL AAVGTVAFGC
     TVQQSSFYGY TGMLPKRYTQ GVMTGESTAG VMISLSRILT KLLLPDERAS TLIFFLVSVA
     LELLCFLLHL LVRRSRFVLF YTTRPRDSHR GRPGLGRGYG YRVHHDVVAG DVHFEHPAPA
     LAPNESPKDS PAHEVTGSGG AYMRFDVPRP RVQRSWPTFR ALLLHRYVVA RVIWADMLSI
     AVTYFITLCL FPGLESEIRH CILGEWLPIL IMAVFNLSDF VGKILAALPV DWRGTHLLAC
     SCLRVVFIPL FILCVYPSGM PALRHPAWPC IFSLLMGISN GYFGSVPMIL AAGKVSPKQR
     ELAGNTMTVS YMSGLTLGSA VAYCTYSLTR DAHGSCLHAS TANGSILAGL
//
